AMPE News and Press, Ampio Pharmaceuticals Inc. From 07/10/19

ENGLEWOOD, Colo. , July 10, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a development stage biopharmaceutical company focused on the discovery and development of a novel therapy aimed at treating common inflammatory conditions for which there are limited t...

ENGLEWOOD, Colo. , June 19, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio"), today announced that it closed its previously announced public offering.  Ampio issued 30,000,000 shares of common stock at an offering price of $0.40 per common share...

Ampio Pharmaceuticals (NYSEMKT: AMPE ) has entered into purchase agreements for the purchase of 25,320,000 common shares at $0.40 per share, for gross proceeds of $10.1M. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

ENGLEWOOD, Colo. , June 17, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced today that it will offer up to $12 Million of its common stock in public offering.  Ampio has entered into purchase agreements for the purchase of an aggrega...

Ampio Pharmaceuticals (NYSEMKT: AMPE ) sinks 22%  in after-hours trading after announcing plans for a common stock offering . More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

ENGLEWOOD, Colo. , June 14, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio"), today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Ampio expects to grant the underwriters a 45-day option to pu...

Ampio Pharmaceuticals (NYSEMKT: AMPE ) announces that it landed FDA approval of its special protocol assessment of a clinical protocol. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

ENGLEWOOD, Colo. , June 14, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announced today that it received FDA approval of the Company's special protocol assessment (SPA) of a clinical protocol titled "A Randomized, Controlled, Double-Blind Study to Evaluate the ...

Introduction Every year the Russell Indexes are rebalanced to bring in new stocks and remove underperforming stocks. The FTSE Russell calls this event the annual reconstitution process, and it begins with evaluations in May and moves to the selection process on June 7th with the newly recons...

ENGLEWOOD, Colo. , May 22, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced updates on subjects of interest to shareholders. Clinical:  The results of the AP-003-C open label extension study outlining the safety and efficacy of re...